Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...

A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...

When it comes to lung cancer, we know of more than 30 substances that are carcinogenic. But when researchers began ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Since its European debut in 2021 [2], Radelumin has become a widely adopted tool for early detection, staging, and recurrence ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...